Recombinant human granulocyte‐macrophage colony‐stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers
- 1 May 1999
- journal article
- clinical trial
- Published by Wiley in International Journal of Dermatology
- Vol. 38 (5) , 380-386
- https://doi.org/10.1046/j.1365-4362.1999.00665.x
Abstract
Background Chronic venous leg ulcers have a major medical and economic impact on the elderly worldwide. Healing of the large ulcers (>10 cm2 ) occurs only in two‐thirds of the patients and reulcerat...Keywords
This publication has 27 references indexed in Scilit:
- Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcersThe American Journal of Surgery, 1997
- GM-CSF Activates Regenerative Epidermal Growth and Stimulates Keratinocyte Proliferation in Human Skin In VivoJournal of Investigative Dermatology, 1994
- Treatment of non-healing ulcers with rhGM-CSF and skin graftsThe Lancet, 1994
- Occlusive dressings and wound healingClinics in Dermatology, 1994
- Leg ulcersJournal of the American Academy of Dermatology, 1991
- Chronic leg ulcers: an underestimated problem in primary health care among elderly patients.Journal of Epidemiology and Community Health, 1991
- Epidemiology of chronic venous ulcersBritish Journal of Surgery, 1991
- Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferateNature, 1989
- Chronic ulceration of the leg: extent of the problem and provision of care.BMJ, 1985
- Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the Skin of the Young Domestic PigNature, 1962